Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00236)

DIG Name
Haematite red
Synonyms
HEMATITE; Iron ore; 1317-60-8; Iron(III)oxide; iron(3+);oxygen(2-); Raphisiderite; Specularite; Haematite; Oligist; Miox; Iron, specular; Red Iron ORE; CCRIS 4377; HSDB 2964; EINECS 215-275-4; ACMC-20p1cs; EC 215-275-4; DTXSID0029632; AKOS025296075; Haematite, underground mining with exposure to radon [Haematite and ferric oxide]; FT-0627296; Q103223; Q419170; Haematite, underground mining with exposure to radon; UNII-2RF6EJ0M85 component LIKBJVNGSGBSGK-UHFFFAOYSA-N
DIG Function
Colorant
Formula
Fe2O3
Canonical SMILES
[O-2].[O-2].[O-2].[Fe+3].[Fe+3]
InChI
1S/2Fe.3O/q2*+3;3*-2
InChIKey
LIKBJVNGSGBSGK-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 159.69 Topological Polar Surface Area 3
XlogP N.A. Complexity 0
Heavy Atom Count 5 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

65 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Alectinib DMP1I6Y Lung cancer [2C25.0] Alectinib Hydrochloride eq 150mg base capsule F23327
Aliskiren DM1BV7W Hypertension [BA00-BA04] Aliskiren Hemifumarate eq 150mg base tablet F23935
Alogliptin DM8WI3R Type-2 diabetes [5A11] Alogliptin Benzoate eq 6.25mg base tablet F23937
Alpelisib DMEXMYK Breast cancer [2C60-2C65] Alpelisib 50mg tablet F24013
Baricitinib DM4ONW5 Rheumatoid arthritis [FA20] Baricitinib 1 mg tablet F24020
Bisoprolol DM3UZ95 Hypertension [BA00-BA04] Bisoprolol Fumarate 5mg tablet F23385
Bosutinib DMTI8YE Breast cancer [2C60-2C65] Bosutinib Monohydrate eq 400mg base tablet F23389
Cabozantinib DMIYDT4 Thyroid cancer [2D10] Cabozantinib S-Malate eq 80mg base capsule F23394
Capmatinib DMYCXKL Non-small-cell lung cancer [2C25.Y] Capmatinib eq 150mg base tablet F23099
Cenobamate DMGOVHA Complex partial seizure [8A68.0] Cenobamate 25 mg tablet F23673
Cholic acid DM7OKQV Peroxisomal disorder [5C57] Cholic Acid 50mg capsule F23679
Clofazimine DMEBOFW Crohn disease [DD70] Clofazimine 100mg capsule F23118
Dabrafenib DMX6OE3 Melanoma [2C30] Dabrafenib Mesylate eq 50mg base capsule F23952
Elagolix sodium DMRDUC0 Endometriosis [GA10] Elagolix Sodium 200 mg tablet F23730
Eltrombopag DMOGFIX Thrombocytopenia [3B64] Eltrombopag Olamine eq 75mg acid tablet F23440
Enzalutamide DMGL19D Prostate cancer [2C82.0] Enzalutamide 40mg tablet F24056
Eprosartan DM07K2I Hypertension [BA00-BA04] Eprosartan Mesylate eq 400mg base tablet F23443
Fedratinib DM4ZBK6 Myelofibrosis [2A20.2] Fedratinib 100 mg capsule F23165
Fenoprofen DML5VQ0 Rheumatoid arthritis [FA20] Fenoprofen Calcium eq 200mg base capsule F23448
Fexofenadine DM17ONX Allergic rhinitis [CA08.0] Fexofenadine Hydrochloride 180mg tablet F23449
Fostamatinib DM6AUHV Immune thrombocytopenic purpura [3B64.13] Fostamatinib 100 mg tablet F24308
Fostemsavir DM50ILT Human immunodeficiency virus infection [1C62] Fostemsavir 600mg Extended-Release tablet F23173
Gilteritinib DMWQ4MZ Acute myeloid leukaemia [2A60] Gilteritinib 40 mg tablet F23180
Ibrutinib DMHZCPO Mantle cell lymphoma [2A85.5] Ibrutinib 280mg tablet F23772
IPI-145 DMWA24P Follicular lymphoma [2A80] Duvelisib 15 mg capsule F24050
Istradefylline DM20VSK Parkinson disease [8A00.0] Istradefylline 20 mg tablet F23204
Ivabradine DM0L594 Angina pectoris [BA40] Ivabradine Hydrochloride eq 5mg base tablet F23963
Lasmiditan DMXLVDT Migraine [8A80] Lasmiditan 100 mg tablet F23800
LGX818 DMNQXV8 Melanoma [2C30] Encorafenib 75 mg capsule F23152
Linagliptin DMWFJTR Type-2 diabetes [5A11] Linagliptin 5mg tablet F23211
Lonafarnib DMGM2Z6 Hutchinson-Gilford progeria syndrome [LD2B] Lonafarnib 50 mg capsule F24392
Lorcaserin DMG6OYJ Obesity [5B81] Lorcaserin Hydrochloride 20mg tablet F23473
Lorlatinib DMICDLV Non-small-cell lung cancer [2C25.Y] Lorlatinib 100 mg tablet F24310
Lusutrombopag DMH6IKO Thrombocytopenia [3B64] Lusutrombopag 3 mg tablet F23221
Mirabegron DMS1GYT Overactive bladder [GC50.0] Mirabegron 25mg extended release tablet F23822
Moexipril DM26E4B Hypertension [BA00-BA04] Moexipril Hydrochloride 7.5mg tablet F23486
Naloxegol DML0B41 Opioid-induced constipation [DB32.1] Naloxegol Oxalate eq 12.5mg base tablet F23971
Naltrexone DMUL45H Alcohol dependence [6C40.2] Naltrexone Hydrochloride 50mg tablet F23492
Nilotinib DM7HXWT Chronic myelogenous leukaemia [2A20.0] Nilotinib Hydrochloride Monohydrate eq 50mg base capsule F23493
Osilodrostat DMIJC9X Cushing disease [5A70] Osilodrostat eq 10mg base tablet F23849
Osimertinib DMRJLAT Non-small-cell lung cancer [2C25.Y] Osimertinib Mesylate eq 40mg base tablet F23977
Ozanimod DMT6AM2 Multiple sclerosis [8A40] Ozanimod 0.23 mg capsule F24103
Panobinostat DM58WKG Multiple myeloma [2A83] Panobinostat Lactate eq 15mg base capsule F23505
Paroxetine DM5PVQE Depression [6A70-6A7Z] Paroxetine Hydrochloride eq 12.5mg base extended release tablet F23507
PF-04449913 DMSB068 Chronic myelomonocytic leukaemia [2A40] Glasdegib 100 mg tablet F24309
Pimavanserin DMR7IVC Parkinson disease [8A00.0] Pimavanserin Tartrate 10 mg tablet F23516
Prasugrel DM7MT6E Acute coronary syndrome [BA41] Prasugrel Hydrochloride eq 10mg base tablet F23518
Quinapril DMR8H31 Hypertension [BA00-BA04] Quinapril Hydrochloride eq 10mg base tablet F24436
R0-93877 DMM4U9G Constipation [DD91.1] Prucalopride 2 mg tablet F23875
Raltegravir DMYURI6 Human immunodeficiency virus infection [1C62] Raltegravir Potassium eq 25mg base Chewable tablet F23529
Relugolix DMK7IWL Prostate cancer [2C82.0] Relugolix 120 mg tablet F23267
Ribociclib succinate DM9CIUW Breast cancer [2C60-2C65] Ribociclib Succinate 200mg tablet F23272
Safinamide DM0YWJC Parkinson disease [8A00.0] Safinamide Mesylate 100 mg tablet F24312
Saquinavir DMG814N Human immunodeficiency virus infection [1C62] Saquinavir Mesylate eq 200mg base capsule F23546
Siponimod DM2R86O Multiple sclerosis [8A40] Siponimod 0.25mg tablet F23895
Sumatriptan DMVYXR8 Migraine [8A80] Sumatriptan Succinate eq 25mg base tablet F23552
Tafenoquine DM1XT4N Malaria [1F40-1F45] Tafenoquine 150 mg tablet F23913
Talazoparib DM1KS78 Breast cancer [2C60-2C65] Talazoparib 0.25 mg capsule F24298
Tazemetostat DMWP1BH Follicular lymphoma [2A80] Tazemetostat 200 mg tablet F23299
Tofacitinib DMBS370 Rheumatoid arthritis [FA20] Tofacitinib Citrate eq 22mg base extended release tablet F23570
Topotecan DMP6G8T Ovarian cancer [2C73] Topotecan Hydrochloride eq 0.25mg base capsule F23577
Trametinib DM2JGQ3 Melanoma [2C30] Trametinib Dimethyl Sulfoxide eq 2mg tablet F23581
Triclabendazole DMPWGBR Helminth infection [1F90.0] Triclabendazole 250 mg tablet F23315
Upadacitinib DM32B5U Rheumatoid arthritis [FA20] Upadacitinib 15 mg Extended-Release tablet F23318
Vortioxetine DM6F1PU Major depressive disorder [6A70.3] Vortioxetine Hydrobromide eq 15mg base tablet F23600
------------------
⏷ Show the Full List of 65 Approved Drug(s)
2 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
HKI-272 DM6QOVN Breast cancer [2C60-2C65] Neratinib Maleate 40 mg tablet F23351
Selumetinib DMC7W6R Melanoma [2C30] Selumetinib 25 mg capsule F23892
------------------
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Discovery agent [N.A.] Oxybutynin 5mg extended release tablet F23499
------------------